Study Objectives: The aim of the study was to investigate the relationship between genetic factors and primary restless legs syndrome (RLS) in Chinese population. Methods: A total of 116 RLS patients and 200 controls were recruited and the diagnosis of RLS was based on the criteria of International RLS Study Group. Polymer chain reaction (PCR) and sequencing were used to detect 19 single nucleotide polymorphisms (SNPs) in six genetic loci (MEIS1, BTBD9, PTPRD, MAP2K5/SKOR1, TOX3, and Intergenic region of 2p14). Results: Our study found that one SNP increased the risk of RLS in Chinese population: rs6494696 of MAP2K5/SKOR1 (odds ratio [OR] = 0.09, p < .0001, recessive model). A further meta-analysis of RLS in Asian population found that two SNPs of BTBD9 increased the risk of RLS: rs9296249 of BTBD9 (OR = 1.44, p = .000, T allele), rs9357271 of BTBD9 (OR = 1.38, p = .021, dominant model). Conclusion: Our results confirmed the association of BTBD9 and MAP2K5/SKOR1 with primary RLS in Chinese population.
INTRODUCTION
Restless legs syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move legs. 1, 2 The characteristics of this disease are worsening at night and continued walking or moving around to alleviate the uncomfortable sensations, which usually cause insomnia in severe cases and affect their quality of daily lives. 3, 4 Genetic factors play an important role in the pathogenesis of RLS. 5, 6 Linkage studies identified eight suspected genetic loci accounting for RLS. [7] [8] [9] [10] [11] [12] In addition, genome wide association study (GWAS) showed that several single nucleotide polymorphisms (SNPs) were associated with the risk of RLS, including MEIS1, BTBD9, PTPRD, MAP2K5, TOX3, and Intergenic region of 2p14. [13] [14] [15] [16] [17] A low prevalence of RLS is reported in Asian countries in comparison to Caucasian population, suggesting different racial factors in RLS. [18] [19] [20] [21] [22] [23] [24] Three studies from Asian population (Korean and Taiwan of China) confirmed the association of BTBD9, MEIS1 and PTPRD with RLS in Asian population. 17, 25, 26 However, two studies from Taiwan of China only focused on certain types of RLS patients, for example, RLS with migraine or renal dysfunction associated RLS. It remains unknown whether the genetic risk factors of all primary RLS are the same as certain types of RLS. Thus, in this study, we selected 20 SNPs within the above six suspected RLS risk genetic loci (MEIS1, BTBD9, PTPRD, MAP2K5/SKOR1, TOX3 and Intergenic region of 2p14) to further test the relationship of these genetic risk factors with primary RLS in Chinese population.
METHODS

Study Population
RLS was diagnosed by RLS specialist based on revised International RLS Study Group diagnostic criteria. 27 Secondary RLS were excluded from this cohort, such as RLS with renal dysfunction, Parkinson's disease, iron deficiency, diabetes, peripheral neuropathy, anemia, pregnancy, or medication induced RLS. Control subjects were recruited through healthy community and evaluated by RLS specialists for exclusion of RLS. International RLS Study Group Rating Scale (IRLSSG) was used to assess the severity of RLS. 28 Information for treating RLS was also obtained. All participants signed consent forms and this study was approved by the ethic committee of Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine.
DNA Preparations and Genotyping
About 2 mL blood samples were collected from RLS patients and controls. DNA was extracted using phenol-chloroform-isopropyl alcohol method. 29 Primers were designed using the tool of Primer-BLAST at National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi?LINK_LOC=BlastHome). SeqMan software was used to identify SNPs. Primers of SNPs were synthesized by Invitrogen. Details of primers and reaction conditions of polymer chain reaction (PCR) ( Supplementary Table S1 ) and the reaction system of PCR (Supplementary Table S2) were described.
Statistical Analysis
Statistical analysis was performed using SAS (version 9.4 TS1M2; SAS Institute Inc., Cary, NC) software package. Student t test was used to compare the differences of age and gender between RLS sufferers and non-RLS controls. Chi-Square test was used in assessing Hardy-Weinberg equilibrium (HWE), genotype and allele of all SNPs distribution between RLS and controls. Risk analysis was performed by logistical regression model
Statement of Significance
Revealing the genetic basis of RLS is crucial for investigating the pathogenesis of RLS. The genetic study of mainland Chinese RLS is very rare. This is the first study to investigate the genetic risk factors of primary RLS in Chinese population. Among 19 selected SNPs, we firstly confirmed the association of BTBD9 and MAP2K5/SKOR1 with primary RLS in Chinese mainland population, suggesting that BTBD9 and MAP2K5/SKOR1 play an important role in the pathogenesis of RLS.
and odds ratio (OR) was calculated with 95% confidence intervals (CI) for each SNP or haplotype according to dominant or recessive models, after adjusting for age and sex. Cochran-Armitage trend test was used to calculate allele dosage. Haploview software was used to test linkage disequilibrium (LD) of SNPs in the same chromosome (Supplementary Tables S3-S6 
Meta Analysis
We searched three databases (Pubmed, Embase, and EBSCO) from inception to December 2016 with no language limitation, using the following search terms: "(restless legs *) AND (variant OR polymorphism)". Then we only included studies that were performed in Asian population. The inclusion criteria were studies reported genotypes or ORs. The exclusion criteria were studies included secondary RLS patients, or that controls were not from general population. Eligible articles were reviewed independently by two investigators (GL and HT). We resolved discrepancies by discussion with a senior investigator (JM). I 2 were used to test the inter-study heterogeneity. If I 2 value was above than 50%, which means significant heterogeneity, random effect model would be used. Comprehensive Meta Analysis (Version 2.2.064) was adopted to perform meta-analysis.
RESULTS
Totally, 125 RLS patients and 200 controls were enrolled in this study. However, 9 RLS had low ferritin and thus were excluded. Finally, 116 RLS and 200 controls were recruited. There are no significant differences of age and gender between RLS patients and controls ( Table 1 ). The average of IRLSSG Rating Scale of RLS group is 21.41 ± 2.58. About 29 of total recruited RLS (25.0%) were familial, 69 (59.5%) were female and 59 (50.86%) were on medication for treating RLS. Among 20 selected SNPs, all were in HWE except for one SNP, rs3104767 of TOX3, which was therefore excluded from our study. Two SNPs of BTBD9 were shown significantly associated with the risk of RLS in our RLS cohort, allele T of rs9296249 (OR = 1.44, p = .026) and allele T of rs9357271 (OR = 1.73, p = .020). Cochran-Armitage trend test showed that there was allele dosage effect of these two SNPs of BTBD9 (p = .023 for rs9296249, p = .016 for rs9357271). However, these two SNPs of BTBD9 did not remain statistical significance after correcting p value by Bonferroni method ( Table 2) .
In addition, three SNPs of MAP2K5/SKOR1 were found associated with RLS in our cohort (rs6494696: OR = 0.09, p < .0001, recessive model; rs11635424: OR = 1.67, p = .038, dominant model; rs12593813: OR = 1.70, p = .038, dominant model). Cochran-Armitage trend test showed that there was allele dosage effect of two SNPs of MAP2K5/SKOR1 (p = .021 for rs11635424; p = .019 for rs12593813). However, after correcting p value, only rs6494696 of MAP2K5/SKOR1 in a recessive model remained statistical significant (p corrected = 9 × 10 -4 ) ( Table 2 ).
In the haplotypes analysis, a haplotype block of MAP2K5/ SKOR1, consisting of seven SNPs from rs1026732 to rs12593813 (of which rs11635424 and rs12593813 tagged risk allele G), was found strongly associated with RLS risk than each single SNP in this block (OR = 2.48, p = .002). A haplotype of BTBD9, consisting of rs9296249 and rs9357271 tagged the risk allele T, was found increased the risk of RLS (OR = 1.89, p = .017), similar effect of each single SNP in this haplotype (Table 3) .
In meta-analysis, a total of 10 articles were found in regarding to RLS genetic association study in Asian population, from Korea and Taiwan. Among them, eight articles were excluded because they were focusing on secondary RLS, such as antipsychotics-related RLS in schizophrenia and end stage renal disease associated RLS. In addition, one article from Taiwan was excluded because the control sample was from migraine instead of general population. Therefore, only one article from Korean was included in our meta-analysis. 26 A total of 433 RLS patients and 518 controls were included in our meta-analysis. The results showed that only two SNPs of BTBD9 were significantly associated with RLS in Asian population: rs9296249 (OR = 1.44, p = .000, T allele), rs9357271 (OR = 1.38, p = .021, dominant model). Besides, we found tendency of association of PTPRD with RLS (rs4626664, dominant model; rs1975197, recessive model) ( Table 4) . 
DISCUSSION
This is the first study demonstrating the association of BTBD9 and MAP2K5/SKOR1 with primary RLS in Chinese population. We explored 19 SNPs harbored in six possible RLS genes loci, including MEIS1, BTBD9, PTPRD, MAP2K5/SKOR1, TOX3 and intergenic region of 2p14. Among them, one SNPrs6494696 of MAP2K5/SKOR1 were significantly associated with RLS. Two haplotypes, one in BTBD9 and the other in MAP2K5/SKOR1 were also found significantly associated with the risk of Chinese RLS. BTBD9 (rs3923809, rs9296249, rs9357271) were first found associated with RLS in Caucasian cohorts.
14, 15 The association of BTBD9 was confirmed in Asian population, the Korean study and our meta-analysis study. 26 However, studies from Taiwan cohorts did not replicate the association of BTBD9 with RLS. 17, 25 One possibility is that BTBD9 might be more associated with PLMS, which is quiet common in RLS. 15, [32] [33] [34] However, only RLS patients with migraine or renal disease were enrolled in the Taiwan cohorts. In addition, Taiwan cohort focusing on RLS with migraine only screened rs3923809, rs7740763 and rs9349077 in BTBD9. 17 Basic science studies found that transgenic animal models targeting on BTBD9 demonstrated motor restless, sensory disturbance and altered level of iron, which are common clinical manifestations of RLS. 33, 34 Another positive finding of our study is the association of MAP2K5/SKOR1 with RLS, which was firstly reported in Caucasian population. 35, 36 The consistency of our finding with others is that the frequently reported rs6494696 from most Caucasian population studies, were also found associated with RLS in our cohort. 14, 36, 37 This finding indicates the importance of MAP2K5/SKOR1in the pathogenesis of RLS. Unfortunately, Korean study on primary RLS included in our meta-analysis investigated rs1026732 instead of rs6494696 and the result The statistical significances remained after using Bonferroni correction. There are some limitations in our study. Firstly, because of low RLS prevalence in China, the number of RLS patients recruited in our study is relatively small. 18 Therefore the power of our study is low (Table 2) . A meta-analysis was further performed in Asian population to increase the sample size and only one Korean study was included. Although this method increased the sample size to some degree (case/control: 433/518), it was still not big enough to detect small effect of risk gene. In addition, allele frequency and odds ratio from Korean study were quite different from our study, especially for PTPRD. Therefore, the statistical power remained low after meta-analysis. Similar studies with big sample size or other method such as GWAS are warranted for further revealing the genetic basis of RLS in Asian population. Secondly, we did not examine all RLSrelated SNPs found in recent studies such as MAOA, HMOX1, VDR, and NOS1. [38] [39] [40] [41] [42] Our results suggested that BTBD9 and MAP2K5/SKOR1 are associated with RLS in Asian population. Unfortunately, we did not replicate the association of MEIS1, PTPRD, TOX3/BC034767 and intergenic region of 2p14 with RLS. Heterogeneity of ethnic origin and small sample size might account for the differences of our results with others. More large RLS cohorts are needed to explore the genetic risk factors for RLS in Asian population in the future. 
